Medicines In Development: Hope For The Future

Wednesday, March 1, 2006

will lake Sari! font sale pext nesdiy hue use and th vil apgiar on E an. ong tal oo ‘he& lhe weae v insey i al A Pt an a] OF OLDER AMERICANS Medicines In Development: Hope For The Future (NAPSA)—According to a report released by the Pharmaceutical Research and Manufacturersof America (PhRMA), more than 900 new medicines are now in the research and developmentpipeline to treat the diseases of aging. The new medicines include 146 medicines for heart disease and stroke and 399 for cancer. Alzheimer’s disease alone could afflict 16 million people by the middle of this century; America’s researchbased pharmaceutical companies are currently developing 27 medicines to treat it. Other medicines now being researched include: 48 for diabetes, of which half of all cases occur in people over age 55. A new, first-in-class medicine in development has been shown in clinical trials to significantly improve long-term glycemic control; 20 for osteoporosis, a major health threat for an estimated 44 million Americans age 50 and older; and 19 to treat depression, which affects an estimated 6.5 million Americans 65 andolder; e 17 for Parkinson’s disease, 60,000 new cases of which are diagnosed each year. A nervous system growth factor gene therapy being studied aims to deliver the growth factor, GDNF, into the brain to prevent degeneration of nerve cells and the loss of the neurotransmitter dopamine. Other medicines in development target bladder and kidney diseases, eye disorders, gastrointestinal disorders, osteoarthritis, pain, prostate disease, respiratory and lung disorders, rheumatoid arthritis, skin conditions, age- New medicines in development may help treat or prevent many of the diseases that affect people as they age. related macular degeneration and other conditions of aging. All of these medicines are either now in humanclinical trials or are awaiting the approval of the Food and Drug Administration. “As life expectancy increases, older Americansface challenges to their health, productivity and independence,” said PhRMApresident and CEO Billy Tauzin. “Research-based pharmaceutical companies are actively searching for treatments and cures to help patients live healthier lives as they age.” The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier and more productive lives. To learn more, visit www.phrma.org and www.innovation.org.

--- PHOTOS ---

File: 20190731-154038-20190731-154036-68206.pdf.jpg

--- FILES ---

File: 20190731-154036-68206.pdf